Search

everythinglearnresearchcommunity

for

Search:↓

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Social media can help compare the effectiveness and safety of new arthritis medications.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Minoxidil cream can safely treat hair loss in kids with ectodermal dysplasia.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

Acitretin may cause salivary gland inflammation.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Abatacept may help some people with alopecia areata regrow hair.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Finasteride helped treat a 28-year-old's facial skin condition.

Blocking interferon-gamma might help treat various autoimmune diseases.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

TNF-alpha inhibitors can cause various immune-related skin issues.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

New cytokine-targeted therapies show promise for treating alopecia areata.